Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

User Basic_Football999 discusses concerns about negative dutasteride experiences. Replies suggest dutasteride is effective, but some users may have issues with dosing frequency or genetic factors affecting results.

Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

The conversation is about choosing a consistent Indian hair transplant surgeon, with options including Dr. Alok Sahoo, Dr. Prakash Khute, and Dr. Satya Saraswat. Concerns include natural hairline, long-term results, and surgeon involvement, with mixed reviews on SkinRoots.

The conversation discusses the legitimacy and reputation of various Indian brands of dutasteride, with recommendations for Dr. Reddy's, Cipla's Duprost, and Intas's Veltride/Dutaman as reputable options. The company in question is noted for exporting but is not well-known locally, though it adheres to global standards.

Akshay Kumar's hair restoration appears conservative, likely involving a small-session FUE hair transplant or non-surgical treatments like PRP, with subtle improvements in density and frontal framing. The overall success is rated 3.5/5, with ongoing maintenance suggested for longevity.

People in India are discussing ordering Kintor's KX-826 for hair loss treatment. They also mention sourcing RU58841 from reliable suppliers.

Kintor apologized for using misleading images in their advertisements and promised stricter review processes. They are also considering developing a topical dutasteride formulation.

Users discuss aggressive promotion of Koshine 826, suspecting Kintor employees are behind it. Concerns are raised about its effectiveness, with some preferring alternatives like finasteride and minoxidil.

A 28-year-old shared his successful hair transplant experience using 2800 grafts, oral minoxidil, and finasteride, resulting in a natural look. The procedure cost 1 lakh INR, and recovery took 7 days.

A 26-year-old male underwent a hair transplant with 3610 grafts after using finasteride, dutasteride, and oral minoxidil for hair loss. He was satisfied with the procedure and care but felt his hairline might be too conservative.

Manav from Nagpur shared his positive experience with a hair transplant in Patna, involving 3500 grafts and costing 1.3 lakh. His post-treatment routine includes minoxidil, finasteride 1mg, and supplements.

A user shared their 6-month progress after a 2700 graft hair transplant, noting initial challenges with shedding but visible improvement in hair density and a natural-looking hairline. The procedure cost around 1 lakh INR, and the user expressed satisfaction and increased confidence with the results.

People are discussing the affordability and effectiveness of Indian generic medications for hair loss, specifically oral dutasteride and minoxidil. They mention brands like Dr. Reddy's, Cipla, and KLM, and discuss payment challenges when purchasing from India.

A hair restoration case involved injecting four different doses of Verteporfin into the mid scalp and using Scalp MicroPigmentation (SMP) around the extraction areas. Photos were taken and an update will be shared soon.

The conversation is about a user planning to undergo a hair transplant and seeking information on clinics that perform Verteporfin treatment. A user suggests Dr. Barghouthi might offer this service.

The conversation is about the timeline for Kintor's phase 3 trials for GT20029 and the potential release of the product in three years. It also mentions treatments like Minoxidil, finasteride, and RU58841.

GT20029 and KX826 are promising hair loss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.

A 26-year-old male actor underwent two hair transplant surgeries to enhance his hairline, with the second surgery by Dr. Abhinav Kumar in Patna yielding natural and satisfactory results. He spent approximately Rs 60,000 ($700) for 1200 fine single hair grafts and plans to consider DHT blockers like finasteride and minoxidil to maintain his hair.

A 34-year-old from India shared hair regrowth progress using a treatment kit from Traya, which included minoxidil, finasteride, ayurvedic supplements, oil, and shampoo. The user improved diet, fixed vitamin deficiencies, and adjusted lifestyle habits, attributing most progress to minoxidil and finasteride.

Verteporfin may improve hair transplant outcomes and reduce scarring, potentially allowing patients to avoid finasteride. Dr. Barghouthi seeks collaborations, volunteers, and financial support for research on verteporfin.org.

PTD-DBM therapy for hair loss is being developed by Dr. Kang-Yell Choi, with human testing planned in South Korea. Some clinics in the U.S. offer PTD-DBM/valproic acid therapy, but it hasn't completed trials yet.

A user shared their positive experience with a hair transplant performed by Dr. Timothy Carman, using 1100 grafts via FUT surgery, and reported satisfaction with the results and minimal scarring. The user continues to use minoxidil and finasteride for hair maintenance.

A user shared their positive experience with a hair transplant in Patna, using 1800 grafts to enhance their hairline and temple points. The procedure cost around Rs 85K, and the user is pleased with the natural-looking results.

The conversation discusses patient updates on hair loss treatment with Verteporfin after five months, as reported by Dr. Blake Bloxham. Patients voluntarily sent their progress pictures to Dr. Bloxham.

KX826 shows promise as a hair loss treatment with a 10% increase in hair count, but concerns about Kintor's marketing practices and the systemic effects of treatments like GT20029 and RU58841 remain. Users express skepticism and hope, with some preferring traditional treatments like finasteride and minoxidil.

The conversation is about choosing a local hair transplant surgeon in Southern California, with specific mentions of Dr. Ken Williams, Dr. Varona, Dr. Sean Behnam, Dr. Amir Yazdan, and Dr. Nader. The user prefers not to consider options outside the U.S. due to safety concerns and cost issues with Dr. Mohebi.

The user shared progress on hair regrowth after a third verteporfin procedure, using oral dutasteride, extended-release oral minoxidil, and occasional microneedling. The results were positively received by others.

A user shared their 6-month progress after a 2700 graft hair transplant, noting initial challenges with shedding but visible improvement in hair density and a natural-looking hairline. They mentioned using minoxidil post-surgery and had the procedure done in Patna, India, costing around 1 lakh.

Kintor is potentially pursuing a new hair loss treatment, KT-215, while users express skepticism about the speed and reliability of new product releases. There is a general sentiment that Chinese companies might be more promising in delivering timely solutions.

Kintor plans to release pyrilutamide foam and a plant-based Koshine by year-end, with GT20029 progressing in their pipeline. Users are pleased about the absence of propylene glycol (PG) in the new products.